Journal of Preventive Medicine and Public Health

The Korean Society for Preventive Medicine (대한예방의학회)
권호 표지
DOI QR코드

DOI QR Code

Economic Burden of Colorectal Cancer in Korea

  • Byun, Ju-Young (Department of Preventive Medicine, Korea University College of Medicine) ;
  • Yoon, Seok-Jun (Department of Preventive Medicine, Korea University College of Medicine) ;
  • Oh, In-Hwan (Department of Preventive Medicine, Kyung Hee University College of Medicine) ;
  • Kim, Young Ae (Department of Public Health, Graduate School of Korea University) ;
  • Seo, Hye-Young (Graduate School of Public Health, Korea University) ;
  • Lee, Yo-Han (Department of Preventive Medicine, Korea University College of Medicine)
  • Received : 2012.10.22
  • Accepted : 2014.01.17
  • Published : 2014.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: The incidence and survival rate of colorectal cancer in Korea are increasing because of improved screening, treatment technologies, and lifestyle changes. In this aging population, increases in economic cost result. This study was conducted to estimate the economic burden of colorectal cancer utilizing claims data from the Health Insurance Review and Assessment Service. Methods: Economic burdens of colorectal cancer were estimated using prevalence data and patients were defined as those who received ambulatory treatment from medical institutions or who had been hospitalized due to colorectal cancer under the International Classification of Disease 10th revision codes from C18-C21. The economic burdens of colorectal cancer were calculated as direct costs and indirect costs. Results: The prevalence rate (per 100 000 people) of those who were treated for colorectal cancer during 2010 was 165.48. The economic burdens of colorectal cancer in 2010 were 3 trillion and 100 billion Korean won (KRW), respectively. Direct costs included 1 trillion and 960 billion KRW (62.85%), respectively and indirect costs were 1 trillion and 160 billion (37.15%), respectively. Conclusions: Colorectal cancer has a large economic burden. Efforts should be made to reduce the economic burden of the disease through primary and secondary prevention.

Keywords

References

  1. Ministry of Health and Welfare. Annual report of cancer statistics in Korea in 2010. Seoul: Ministry of Health and Welfare;2012, p. 10-21 (Korean).
  2. Statistics Korea. Causes of death statistics in 2012: incidence and mortality of cancer [cited 2014 Mar 7]. Available from: http://www.index.go.kr/potal/main/EachDtlPageDetail.do?idx_cd=2770 (Korean).
  3. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62(1):10-29. https://doi.org/10.3322/caac.20138
  4. Azrak MF, Yang VW. Colorectal neoplasms. In: Sitaraman SV, Friedman LS, editors. Essentials of gastroenterology. Oxford: Wiley-Blackwell; 2012, p. 132-146.
  5. Jung KW, Park S, Kong HJ, Won YJ, Lee JY, Seo HG, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat 2012;44(1):11-24. https://doi.org/10.4143/crt.2012.44.1.11
  6. Ministry of Health and Welfare. Cancer facts and figures. Seoul: Ministry of Health and Welfare; 2010, p. 13-16 (Korean).
  7. International Agency for Research on Cancer. Colorectal cancer incidence: mortality and prevalence worldwide in 2008 summary [cited 2014 Mar 7]. Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.
  8. Lee BI, Hong SP, Kim SE, Kim SH, Kim HS, Hong SN, et al. Korean guidelines for colorectal cancer screening and polyp detection. Clin Endosc 2012;45(1):25-43. https://doi.org/10.5946/ce.2012.45.1.25
  9. Kim SG, Hahm MI, Choi KS, Seung NY, Shin HR, Park EC. The economic burden of cancer in Korea in 2002. Eur J Cancer Care (Engl) 2008;17(2):136-144. https://doi.org/10.1111/j.1365-2354.2007.00818.x
  10. Kim J, Hahm MI, Park EC, Park JH, Park JH, Kim SE, et al. Economic burden of cancer in South Korea for the year 2005. J Prev Med Public Health 2009;42(3):190-198 (Korean). https://doi.org/10.3961/jpmph.2009.42.3.190
  11. Segel JE. Cost-of-illness studies: a primer; 2006 [cited 2014 Mar 7]. Available from: http://www.rti.org/pubs/coi_primer.pdf.
  12. World Health Organization. ICD-10 International Statistical Classification of Diseases and related health problems: 10th revision; 2010 [cited 2014 Mar 7]. Available from: http://apps.who.int/classifications/icd10/browse/2010/en.
  13. Benson AB 3rd. Epidemiology, disease progression, and economic burden of colorectal cancer. J Manag Care Pharm 2007;13(6 Suppl C):S5-S18.
  14. Hornbrook MC. On the definition and measurement of the economic burden of cancer. In: Lipscomb J, Gotay CC, Snyder C, editors. Outcomes assessment in cancer. Cambridge: Cambridge University Press; 2005, p. 480-502.
  15. Park M, Choi Y, Tae Y, Choi J, Back S, Lee H. Health Insurance Patients Payments Survey (2010). Seoul: National Health Insurance Corporation; 2011, p. 15 (Korean).
  16. Jung YH, Seo NG, Go SG, Han EJ. A report on the Korea Health Panel Survey of 2008. Seoul: Korea Institute for Health and Social Affairs 2010, p. 38 (Korean).
  17. The Korea Patient Helper Society. Nursing pay guide [cited 2014 Mar 7]. Available from: http://www.help114.or.kr/ (Korean).
  18. Statistics Korea. Consumer Price Survey (index) guide; 2010 [cited 2014 Mar 7]. Available from: http://kostat.go.kr/portal/ english/surveyOutlines/4/2/index.static (Korean).
  19. Cartwright WS. Methods for the economic evaluation of health care programmes, second edition. By Michael F. Drummond, Bernie O'Brien, Greg L. Stoddart, George W. Torrance. Oxford: Oxford University Press, 1997. J Ment Health Policy Econ 1999;2(1):43. https://doi.org/10.1002/(SICI)1099-176X(199903)2:1<43::AID-MHP36>3.0.CO;2-7
  20. Ministry of Employment and Labor. Survey on the structure of wages by the Ministry of Labor in Korea; 2007 [cited 2014 Mar 7]. Available from: http://www.moel.go.kr/view.jsp?cate=3&s ec=1&smenu=2&mode=view&bbs_cd=116&state=A&s eq=1167352846789 (Korean).
  21. Kim SG, Hahm MI, ChoiI KS, Seung NY, Shin HR, Park EC. The economic burden of cancer in Korea in 2002. Eur J Cancer Care 2008;17(2):136-144. https://doi.org/10.1111/j.1365-2354.2007.00818.x
  22. Jo HS. Strategies for improvement of primary care in Korea. J Korean Med Assoc 2012;55(10):959-968 (Korean). https://doi.org/10.5124/jkma.2012.55.10.959
  23. Ministry of Health and Welfare. Korean national health accounts and total health expenditure; 2010 [cited 2014 Mar 7]. Available from: https://www.index.go.kr (Korean).
  24. Myong JP, Shin JY, Kim SJ. Factors associated with participation in colorectal cancer screening in Korea: the fourth Korean National Health and Nutrition Examination Survey (KNHANES IV). Int J Colorectal Dis 2012;27(8):1061-1069. https://doi.org/10.1007/s00384-012-1428-4
  25. Shim JI, Kim Y, Han MA, Lee HY, Choi KS, Jun JK, et al. Results of colorectal cancer screening of the national cancer screening program in Korea, 2008. Cancer Res Treat 2010;42(4):191-198. https://doi.org/10.4143/crt.2010.42.4.191
  26. Jung KW, Park S, Won YJ, Kong HJ, Lee JY, Seo HG, et al. Prediction of cancer incidence and mortality in Korea, 2012. Cancer Res Treat 2012;44(1):25-31. https://doi.org/10.4143/crt.2012.44.1.25
  27. Fautrel B, Clarke AE, Guillemin F, Adam V, St-Pierre Y, Panaritis T, et al. Costs of rheumatoid arthritis: new estimates from the human capital method and comparison to the willingness-topay method. Med Decis Making 2007;27(2):138-150. https://doi.org/10.1177/0272989X06297389
  28. Martin-Moreno JM, Anttila A, von Karsa L, Alfonso-Sanchez JL, Gorgojo L. Cancer screening and health system resilience: keys to protecting and bolstering preventive services during a financial crisis. Eur J Cancer 2012;48(14):2212-2218. https://doi.org/10.1016/j.ejca.2012.02.060
  29. Ferrante JM, McCarthy EP, Gonzalez EC, Lee JH, Chen R, Love- Jackson K, et al. Primary care utilization and colorectal cancer outcomes among Medicare beneficiaries. Arch Intern Med 2011; 171(19):1747-1757. https://doi.org/10.1001/archinternmed.2011.470
  30. Martinez ME. Primary prevention of colorectal cancer: lifestyle, nutrition, exercise. In: Senn HJ, Morant R, editors. Tumor prevention and genetics III. New York: Springer; 2005, p. 177-211.

Cited by

  1. FOXM1-mediated downregulation of uPA and MMP9 by 3,3′-diindolylmethane inhibits migration and invasion of human colorectal cancer cells vol.33, pp.6, 2014, https://doi.org/10.3892/or.2015.3938
  2. The Economic Burden of Cancer in Korea in 2009 vol.16, pp.3, 2015, https://doi.org/10.7314/apjcp.2015.16.3.1295
  3. The Economic Burden of Cancers Attributable to Metabolic Syndrome in Korea vol.48, pp.4, 2014, https://doi.org/10.3961/jpmph.15.022
  4. 대전광역시와 충청남도의 13년간(2000-2012) 대장암 발생 추세 vol.40, pp.3, 2014, https://doi.org/10.5393/jamch.2015.40.3.115
  5. The Economic Burden of Hepatitis A, B, and C in South Korea vol.69, pp.1, 2014, https://doi.org/10.7883/yoken.jjid.2014.499
  6. Dehydroglyasperin D Inhibits the Proliferation of HT-29 Human Colorectal Cancer Cells Through Direct Interaction With Phosphatidylinositol 3-kinase vol.21, pp.1, 2014, https://doi.org/10.15430/jcp.2016.21.1.26
  7. Emerging hazard effects of proton pump inhibitor on the risk of colorectal cancer in low-risk populations: A Korean nationwide prospective cohort study vol.12, pp.12, 2014, https://doi.org/10.1371/journal.pone.0189114
  8. Analysis of Productivity Costs in Cancer: A Systematic Review vol.4, pp.1, 2014, https://doi.org/10.5301/grhta.5000262
  9. High Spy1 expression predicts poor prognosis in colorectal cancer vol.10, pp.None, 2014, https://doi.org/10.2147/cmar.s169329
  10. Quality of life and costs of patients prior to colorectal surgery vol.20, pp.2, 2014, https://doi.org/10.1080/14737167.2019.1628641
  11. Socioeconomic Burden of Cancer in Korea from 2011 to 2015 vol.52, pp.3, 2014, https://doi.org/10.4143/crt.2019.398
  12. Economic Burden of Colorectal Cancer: A Case of Fars, Iran vol.28, pp.None, 2014, https://doi.org/10.1177/10732748211009952
  13. The Direct and Indirect Costs of Colorectal Cancer in Vietnam: An Economic Analysis from a Social Perspective vol.18, pp.1, 2014, https://doi.org/10.3390/ijerph18010012
  14. A performance measurement framework for socially sustainable and resilient supply chains using environmental goods valuation methods vol.30, pp.None, 2022, https://doi.org/10.1016/j.spc.2021.11.026